Cnj-016
Vaccinia immune globulin intravenous (human) · Emergent BioSolutions Canada Inc.
PRESCRIPTION ONLY (USA)Cnj-016 ingredients
| Active ingredient | Strength |
|---|---|
| Human Vaccinia Virus Immune Globulin | 1 [iU]/mL |
What Cnj-016 is used for
Cnj-016 is a specialist medicine (human immunoglobulin g). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Cnj-016
- Generic name
- Vaccinia immune globulin intravenous (human)
- Made by
- Emergent BioSolutions Canada Inc.
- Forms
- Injection
- Given
- Intravenous
- Drug class
- Human Immunoglobulin G
- FDA approval
- Biologic licence (BLA) BLA125109
- On the US market since
- 2005
Official information
- Cnj-016 prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Vaccinia immune globulin intravenous (human))
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Cnj-016?
Cnj-016 (Vaccinia immune globulin intravenous (human)) is a specialist medicine made by Emergent BioSolutions Canada Inc., approved by the US FDA.
What are the ingredients of Cnj-016?
Cnj-016 contains Human Vaccinia Virus Immune Globulin (1 [iU]/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA